#liver cancer

Lenvima works as well as standard therapy for metastatic or unresectable cancer.

Benefits include lower rates of cancer recurrence and microvascular invasion, which is associated with poor post-surgery outcomes.

This includes a higher risk of liver cancer, cirrhosis-related complications and death.

Liver cancer rates and deaths have doubled in the United States, Canada, Australia and United Kingdom.

Scientific evidence does not support warning signs about acrylamide cancer risk.

Non-alcoholic fatty liver disease can lead to cirrhosis and liver cancer.

Few people saw their liver disease progress, and there were scant numbers of relapses more than 12 weeks posttreatment in a large study.

Engineered T cells prevent recurrence over five years.

The annual scientific meeting on liver health revealed exciting new findings concerning the battle against the hep C epidemic.

Adding internal radiation or TACE did appear to help certain people, however.

This is according to a recent mathematical modeling study.

Liver cancer development is strongly associated with hep B.

Cure rates were near 100 percent even though the population in the study’s analysis had high rates of other health conditions.

Recommendations now include multiple systemic medications in addition to surgery and local therapies.

Compared with their HIV-negative peers, HIV-positive individuals have higher rates of treatment for a host of health problems.

This finding is specific to those who do not have liver cancer.